FIELD: biotechnology.
SUBSTANCE: disclosed are antibodies which specifically bind to LRP5, containing immunoconjugates and compositions, as well as methods of using them. Also disclosed are nucleic acids coding said antibodies, expression vectors and host cells containing said nucleic acids, a method of producing antibodies.
EFFECT: invention provides a new set of synthetic antibodies targeting extracellular epitopes of LRP5.
28 cl, 9 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
| AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE | 2009 |
|
RU2579897C2 |
| SELECTION OF CANCER PATIENTS FOR INTRODUCTION OF WNT SIGNAL INHIBITORS BASED ON RNF43 MUTATION STATUS | 2013 |
|
RU2636000C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| BLOCKING ANTI-Dkk-1 ANTIBODIES AND APPLICATIONS THEREOF | 2010 |
|
RU2548817C2 |
| MARKERS ASSOCIATED WITH WNT INHIBITORS | 2014 |
|
RU2663701C2 |
| ALPHA5-BETA 1 ANTIBODIES AND USING THEM | 2009 |
|
RU2528736C2 |
| ALLOSTERIC ANTIBODIES AGAINST HUMAN HER3 NON COMPETITIVE FOR NEUREGULIN AND USE THEREOF | 2013 |
|
RU2704228C2 |
| INTEGRIN ανβ8 NEUTRALISING ANTIBODIES | 2011 |
|
RU2565539C2 |
| NOVEL MODULATORS AND METHODS FOR USE THEREOF | 2011 |
|
RU2592672C9 |
